Biosplice Therapeutics Statistics and Revenue Totals for 2024
Last Updated on: January 10th, 2024
Here are a few of the most interesting Biosplice Therapeutics statistics and facts I was able to dig up including restaurant count, revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Critical sections of this article:
- Biosplice Therapeutics Facts
- Biosplice Therapeutics Statistics
- Biosplice Therapeutics Employee Count
- Biosplice Therapeutics Revenue Totals
Biosplice Therapeutics Facts
Here is pretty much everything you ever wanted to know about Biosplice Therapeutics.
- Website: Official Website
- Year Founded: 2008
- Headquarters: San Diego, CA
- Founder(s): Osman Kibar
Biosplice Therapeutics is a biopharmaceutical company focused on pioneering novel therapeutics based on alternative splicing in cellular processes, which is a critical mechanism of post-transcriptional gene control. Their primary research and development efforts are centered on advancing treatments for diseases with significant unmet medical needs, particularly in the area of osteoarthritis and oncology. The company’s innovative approach targets modulation of specific proteins involved in disease progression, aiming to disrupt the underlying biological pathways and provide substantial improvements over existing therapies.
Biosplice Therapeutics Statistics
Biosplice Therapeutics Employee Count
Nothing to report yet. Please check back in the future as we update our data as soon as it is made available by the company.
Biosplice Therapeutics Revenue Totals
Nothing to report yet. Please check back in the future as we update our data as soon as it is made available by the company.
Please note that some of these numbers are easier to find than others. A few of these Biosplice Therapeutics statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags:
